|
|||
2011-09-01 12:00:00 CEST 2011-09-01 12:00:33 CEST REGULATED INFORMATION Biotie Therapies - Changes board/management/auditorsNew interim CFO in BiotieBIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 1 September 2011 at 1 p.m. New interim CFO in Biotie Biotie's interim Chief Financial Officer Ulla Sjöblom will be leaving the company to pursue other interests. Zack McNealy, Vice President, Finance of the group's US subsidiary will assume the role of acting Chief Financial Officer starting September 1, 2011. The Company expects to conclude the ongoing CFO search process by the end of this year. Zack McNealy has been Vice President, Finance of Biotie Therapies, Inc. (formerly Synosia Therapeutics) since 2007. Before this, he served as a Plant Controller, Finance Manager, and Financial Analyst with Johnson & Johnson from 1997-2006. Turku, 1 September 2011 Biotie Therapies Corp. Timo Veromaa President and CEO For further information, please contact: Virve Nurmi, Biotie Therapies Corp. tel. +358 2 274 8900 e-mail: virve.nurmi@biotie.com DISTRIBUTION NASDAQ OMX Helsinki Ltd Main Media www.biotie.com [HUG#1543410] |
|||
|